About
About Venus Remedies Limited
Venus Remedies Limited engages in the pharmaceutical business in India, Latin America, Europe, the Middle East, Africa, Asia, and internationally. The company is involved in the research and development of solutions focusing on antimicrobial resistance, oncology, skin and wound care, and pain management. It also provides analgesic, analgesic and antipyretic, antibiotic, antidiabetic anticoagulant, antiemetic, antiviral, cardiac, cardiovascular, CNS, disinfectant and antiseptic, gastro therapy, gastro therapy, hepatoprotective, hormones (steroid), immunostimulating agent, iron supplements, mucolytic, muscle relaxant, neurology, respiratory, stress reliver, urology, vitamins, nutrients, minerals, and solvent products, as well as herbal medicine. The company was incorporated in 1989 and is headquartered in Panchkula, India.
Research context
Venus Remedies Limited appears in PyInvesting’s India Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- INR
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Visit company website
5 years, 6 months ago
Venus Remedies Limited is currently in a long term uptrend where the price is trading 81.0% above its 200 day moving average.
From a valuation standpoint, the stock is 85.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.7.
Venus Remedies Limited's total revenue rose by 25.9% to $1B since the same quarter in the previous year.
Its net income has increased by 1312.8% to $117M since the same quarter in the previous year.
Finally, its free cash flow fell by 0.0% to $461M since the same quarter in the previous year.
Based on the above factors, Venus Remedies Limited gets an overall score of 4/5.